| HDL-C AND THE METABOLIC SYNDROME: FROM EPIDEMIOLOGY TO TREATMENT STRATEGIES |
| Chairpersons: |
G. Assmann, Germany
R. Carmena, Spain |
1.
EPIDEMIOLOGY OF THE METABOLIC SYNDROME
G. Assman, Germany |
2. PHISIOPATHOLOGY
OF THE METABOLIC SYNDROME
J. Chapman, France |
3. TARGETING
DIABETES AND THE METABOLIC SYNDROME FOR CHD REDUCTION:
A SPECIAL PLACE FOR FIBRATES
S. Robins, USA |
4. COMPARATIVE
EFFICACY OF PRAVASTATIN AND FENOFIBRATE IN PRIMARY DYSLIPIDEMIA
J. Ducobu, Belgium |
5. DAIS:
TREATMENT OF DYSLIPIDEMIA BEYOND LDL CHOLESTEROL
M. R. Taskinen, Finland |
6. LOW HDL-C
RAISING: AN EXPERT PANEL RECOMMENDATION
F. Sacks, USA |
| |
Timetable